FAM49B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.027800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.740300E-02
Normal-vs-Stage2
4.825600E-02
Normal-vs-Stage3
3.518100E-02
Normal-vs-Stage4
1.887000E-01
Stage1-vs-Stage2
5.986400E-01
Stage1-vs-Stage3
4.776800E-01
Stage1-vs-Stage4
8.767400E-01
Stage2-vs-Stage3
3.129000E-01
Stage2-vs-Stage4
8.037200E-01
Stage3-vs-Stage4
5.763800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.529700E-02
Normal-vs-AfricanAmerican
6.223800E-02
Normal-vs-Asian
2.382300E-02
Caucasian-vs-AfricanAmerican
8.237200E-01
Caucasian-vs-Asian
5.510000E-01
AfricanAmerican-vs-Asian
8.224000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.142900E-03
Normal-vs-Female
8.662500E-02
Male-vs-Female
2.137000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.565800E-02
Normal-vs-Age(41-60Yrs)
1.950840E-01
Normal-vs-Age(61-80Yrs)
4.401800E-03
Normal-vs-Age(81-100Yrs)
6.383800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.346600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.219800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.063400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.323670E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.529800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.448600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.582220E-01
Normal-vs-Daily Drinker
2.984500E-02
Normal-vs-Weekly Drinker
1.180190E-02
Normal-vs-Occasional Drinker
2.295200E-01
Normal-vs-Social Drinker
3.890100E-02
Non Drinker-vs-Daily Drinker
7.147800E-01
Non Drinker-vs-Weekly Drinker
4.365800E-01
Non Drinker-vs-Occasional Drinker
2.943600E-01
Non Drinker-vs-Social Drinker
9.864200E-01
Daily Drinker-vs-Weekly Drinker
6.563800E-01
Daily Drinker-vs-Occasional Drinker
9.590400E-02
Daily Drinker-vs-Social Drinker
6.882000E-01
Weekly Drinker-vs-Occasional Drinker
5.438300E-02
Weekly Drinker-vs-Social Drinker
4.013600E-01
Occasional Drinker-vs-Social Drinker
2.255400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.265200E-01
Normal-vs-Grade 2
7.999400E-01
Normal-vs-Grade 3
3.965400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.416610E-01
Grade 1-vs-Grade 3
9.018700E-03
Grade 1-vs-Grade 4
8.265200E-01
Grade 2-vs-Grade 3
5.013500E-02
Grade 2-vs-Grade 4
7.999400E-01
Grade 3-vs-Grade 4
3.965400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.443600E-03
Normal-vs-NonDiabetic
3.916000E-02
Diabetic-vs-NonDiabetic
8.442800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.402800E-03
Normal-vs-NoPancreatitis
3.456000E-02
Pancreatitis-vs-NoPancreatitis
6.520200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.864900E-03
Normal-vs-N1
5.249900E-02
N0-vs-N1
5.568400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.394580E-01
Normal-vs-TP53-NonMutant
2.358000E-03
TP53-Mutant-vs-TP53-NonMutant
4.05780000000133E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
